HEVDUA Trademark

Trademark Overview


On Wednesday, December 30, 2020, a trademark application was filed for HEVDUA with the United States Patent and Trademark Office. The USPTO has given the HEVDUA trademark a serial number of 79305397. The federal status of this trademark filing is REGISTERED as of Tuesday, January 25, 2022. This trademark is owned by Theravance Biopharma Ireland Limited. The HEVDUA trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations and materials, namely, diagnostic preparations for medical and veterinary use; pharmaceutical preparations for treatment of human diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the tr...
hevdua

General Information


Serial Number79305397
Word MarkHEVDUA
Filing DateWednesday, December 30, 2020
Status700 - REGISTERED
Status DateTuesday, January 25, 2022
Registration Number6624377
Registration DateTuesday, January 25, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 9, 2021

Trademark Statements


Goods and ServicesDiagnostic preparations and materials, namely, diagnostic preparations for medical and veterinary use; pharmaceutical preparations for treatment of human diseases of the autonomic, respiratory, endocrine, circulatory, gastrointestinal, genito-urinary, integumentary, immune and central nervous system; pharmaceutical preparations for the treatment of cancer and pain; pharmaceutical preparations and substances for the treatment of respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations and substances for the treatment of ocular and dermatological diseases and disorders; pharmaceutical preparations and substances for the treatment of neurogenic orthostatic hypotension and for the prevention and treatment of low blood pressure; pharmaceutical preparations and substances in the nature of anti-hypotensive and vasopressor agents; pharmaceutical preparations and substances for the treatment of Parkinson's disease and disorders; pharmaceutical preparations and substances for the prevention and treatment of dizziness and lightheadedness; pharmaceutical preparations and substances for the treatment of disorders characterized by a deficiency of norepinephrine; pharmaceutical preparations and substances for the treatment of bacterial and viral infections, namely anti-infectives

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 5, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameTheravance Biopharma Ireland Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressIE

Party NameTheravance Biopharma Ireland Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressIE

Party NameTheravance Biopharma Ireland Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressIE

Trademark Events


Event DateEvent Description
Sunday, July 23, 2023CHANGE OF NAME/ADDRESS REC'D FROM IB
Monday, August 1, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Thursday, July 7, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, July 7, 2022FINAL DISPOSITION PROCESSED
Monday, April 25, 2022FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, January 25, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 9, 2021PUBLISHED FOR OPPOSITION
Wednesday, October 20, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 4, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 1, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, October 1, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, October 1, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, August 15, 2021REFUSAL PROCESSED BY IB
Wednesday, July 28, 2021NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, July 28, 2021REFUSAL PROCESSED BY MPU
Monday, July 19, 2021NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Sunday, July 18, 2021NON-FINAL ACTION WRITTEN
Saturday, July 3, 2021ASSIGNED TO EXAMINER
Tuesday, March 9, 2021APPLICATION FILING RECEIPT MAILED
Friday, March 5, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 4, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB